Growel Formulations Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 1993.
1993 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Growel Formulations Private Limited

Growel Formulations Private Limited, a active private limited company, was established on 29 April 1993 in Hyderabad, Telangana, India. Engaging in animal pharmaceuticals & healthcare within the agriculture, forestry, fishing sector, it holds CIN: U24239TG1993PTC015700. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹8.00 Cr and a paid-up capital of ₹7.21 Cr.

It upholds a compliant status. Employing 104 professional, Its leadership includes Ranga Kirtana Mudumbi (Director), Padma Preeti Mudumbi (Director), Vedadri Narasimha Sesha Chary Mudumbi (Whole-Time Director). Past directors included Ranga Kirtana Mudumbi, Padma Preeti Mudumbi, Neetu Thawardas Lalwani. It holds ₹45.96 Cr open charges and ₹1.75 Cr settled loans. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at Survey No.64-67, Chengicherla Village Road Rangareddy District, Hyderabad, Telangana, 500039.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239TG1993PTC015700

  • Registration Number

    015700

  • Incorporation Date

    29 April 1993

  • Authorized Capital

    ₹8.00 Cr

  • Paid-Up Capital

    ₹7.21 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 8.00 Cr
  • Paid Up Capital ₹ 7.21 Cr
  • Company Age 32 Year, 10 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 45.96 Cr
  • Satisfied Charges ₹ 1.75 Cr
  • Revenue Growth **** 9.12%
  • Profit Growth **** -3.73%
  • Ebitda **** -11.37%
  • Net Worth 20.44%
  • Total Assets **** 7.58%
Company report

Growel Formulations Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Growel Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Growel Formulations Private Limited?
Current Directors
Name Designation Appointment Date Status
Ranga Kirtana Mudumbi Director 24 Aug 2017 Current
Padma Preeti Mudumbi Director 24 Aug 2017 Current
Vedadri Narasimha Sesha Chary Mudumbi Whole-Time Director 28 Dec 2001 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 16 Sep 2017 Past
Pramod Abcsdd Additional Director 16 Sep 2017 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Managing Director 05 Jul 2017 Past
Pramod Abcsdd Whole-Time Director 19 Dec 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Growel Formulations.

Growel Formulations Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.12% increase. The company also saw a slight decrease in profitability, with a 3.73% decrease in profit. The company's net worth Soared by an impressive increase of 20.44%.

Growel Formulations revenue growth over time
Growel Formulations profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 9.12%
*******
*******
*******
*******
Revenue from Operations
*******
 9.11%
*******
*******
*******
*******
Total Assets
*******
 7.58%
*******
*******
*******
*******
Profit or Loss
*******
 -3.73%
*******
*******
*******
*******
Net Worth
*******
 20.44%
*******
*******
*******
*******
EBITDA
*******
 -11.37%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Growel Formulations?

In 2023, Growel Formulations had a promoter holding of 100.00%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹459,625,000.00

Satisfied Charges

₹17,500,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 44.06 Cr
  • Axis Bank Limited : 1.91 Cr
Latest Charge Details
Date Lender Amount Status
27 Jun 2024 State Bank Of India ₹3.00 Cr Open
05 Jul 2022 State Bank Of India ₹2.78 M Open
01 Jul 2020 Axis Bank Limited ₹7.25 M Open
05 Jul 2019 Axis Bank Limited ₹1.18 Cr Open
04 Dec 1995 State Bank Of India ₹40.78 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Growel Formulations?

Growel Formulations has a workforce of 104 employees as of Sep 25, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Growel Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Growel Formulations's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Growel Formulations
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Growel Formulations Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was documented.

  • Charges

    Progress on A charge with State Bank Of India amounted to Rs. 3.00 Cr with Charge ID 100941542 was registered on 27 Jun 2024. was documented.

  • Balance Sheet

    Progress on Growel Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.

  • Charges

    Progress on A charge with State Bank Of India of Rs. 40.78 Cr registered on 04 Dec 1995 with Charge ID 90123832 was modified on 20 Mar 2023. was documented.

  • Charges

    Progress on A charge with State Bank Of India amounted to Rs. 0.28 Cr with Charge ID 100604892 was registered on 05 Jul 2022. was documented.

  • Charges

    Progress on A charge registered on 24 Feb 2001 via Charge ID 90122948 with State Bank Of India was fully satisfied on 07 May 2022. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Growel Formulations Private Limited?

The CIN of Growel Formulations Private Limited is U24239TG1993PTC015700.

Where is Growel Formulations Private Limited headquartered?

Growel Formulations Private Limited is headquartered at Survey No.64-67, Chengicherla Village Road Rangareddy District, Hyderabad, Telangana, 500039.

When was Growel Formulations Private Limited incorporated?

Growel Formulations Private Limited was incorporated on 29 April 1993.

Who are the current directors of Growel Formulations Private Limited?

The current directors of Growel Formulations Private Limited are

What is the primary industry of Growel Formulations Private Limited?

The primary industry of Growel Formulations Private Limited is Agriculture, Forestry, Fishing.

Is Growel Formulations Private Limited a listed company?

Growel Formulations Private Limited is unlisted.

What is the capital structure of Growel Formulations Private Limited?

The authorized capital of Growel Formulations Private Limited is ₹8.00 Cr, and the paid-up capital is ₹7.21 Cr.

What is the compliance status of Growel Formulations Private Limited?

The compliance status of Growel Formulations Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available